Ken Fisher acquired 92.1 Thousand Neurocrine Biosciences shares worth $10.7 Million. That's 0.00% of their equity portfolio (405th largest holding). The first Neurocrine Biosciences trade was made in Q3 2017. Since then Ken Fisher bought shares ten more times and sold shares on nineteen occasions. The stake costed the investor $8.97 Million, netting the investor a gain of 19% so far.